Be an Advocate for Yourself
March 20, 2020
Patients Deserve Better
March 22, 2020

Autoimmune Disease Awareness: A Timely, National Priority

Autoimmune Disease Awareness Month (ADAM) is our time to speak up to increase understanding of the prevalence, impact, challenge, and opportunity facing an estimated 50 million Americans living with autoimmune diseases. The stakes have never been higher. People with one or more of the 100+ specific autoimmune conditions have stories to tell, contributions to make, commitment to research, and hope for new treatments. Yet, too many confront a too-long list of barriers between them and the medicines and care that they need to lead healthy, full lives.

The American Autoimmune Related Diseases Association – AARDA – is dedicated to breaking down these barriers. ADAM is a call to action. And everyone is encouraged to participate.
Raising awareness about the presence of autoimmune disease is especially critical in his time of global pandemic. People with autoimmune conditions are among those with underlying health conditions that put them at greater risk of experiencing serious consequences if they contract this novel coronavirus, COVID-19. AARDA has relevant information and resources on our website, including links to government, academic, patient group, and other sources of advice and expertise.

For nearly 30 years, AARDA has been a pioneer and leader in advocating for all autoimmune diseases, actively collaborating with patients, doctors, and other stakeholders to raise awareness about autoimmunity, drive public policy changes, and promote increased investment in research and discovery.

AARDA is committed to advocating for those living with autoimmune diseases, and we welcome your help. Join us to raise awareness, engage, advocate, and support our cause. Click here for ideas and opportunities to get involved.

1 Comment

  1. […] there are more than 50 million Americans living with autoimmune diseases. For many of these Americans, their autoimmune disease presents […]

Leave a Reply

Your email address will not be published. Required fields are marked *